EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Prevalence of depression in melasma: a systematic review and meta-analysis

Prävalenz von Depression bei Melasma: systematische Übersicht und Metaanalyse

Wenjing Chen, Yue Wan, Yuan Sun, Changyong Gao, Jianhong Li

Frontiers in Psychiatry · 08.01.2024 · 14

DOI: 10.3389/fpsyt.2023.1276906 ↗

Auf einen Blick

Die Metaanalyse fand bei Patient:innen mit Melasma eine gepoolte Depressionsprävalenz von 43,4 %. Gegenüber gesunden Kontrollen war Depression häufiger.

Fragestellung

Wie hoch ist die Prävalenz von Depression bei Melasma?

Methode

Systematische Übersichtsarbeit und Metaanalyse; Suche in PubMed, Embase, Web of Science und Scopus bis 12. Juli 2023.

Ergebnisse

16 Studien mit 2.963 Patient:innen. Gepoolte Prävalenz 43,4 % (95 %-KI 30,5–56,2 %); depressive Störungen 24,2 % (95 %-KI 16,8–31,6 %), depressive Symptome 45,1 % (95 %-KI 31,2–59,0 %). OR 1,677 (95 %-KI 1,163–2,420).

Schlussfolgerung der Autor:innen

Die Prävalenz von Depression war bei Melasma relativ hoch, und es bestand ein Zusammenhang zwischen Melasma und Depression.

Kernaussagen

  • Gepoolte Depressionsprävalenz bei Melasma: 43,4 %
  • OR für Depression vs. gesunde Kontrollen: 1,677
  • Asia hatte die höchste Prävalenz: 48,5 %

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Psychiatry, online erschienen am 08.01.2024. Verfasst von Wenjing Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College of Beijing University of Chinese Medicine, Beijing, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Due to cosmetic disfigurement, melasma can negatively affect the quality of life and emotional and mental health, further leading to depression.

Objective

Prevalence rates of depression in patients with melasma vary widely across studies. The aim of this systematic review and meta-analysis was to estimate the prevalence of depression among melasma patients.

Methods

The PubMed, Embase, Web of Science, and Scopus databases were searched to identify articles evaluating the prevalence of depression in melasma patients from their inception to 12 July 2023. Studies were reviewed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and a meta-analysis was performed using the Stata 14.0 software.

Results

Sixteen studies met the eligibility criteria out of the 859 studies, containing a total of 2,963 melasma patients for this systematic review and meta-analysis. Meta-analyses revealed that the pooled prevalence of depression among patients with melasma was 43.4% (95% CI 30.5–56.2%, Q -value = 808.859, d.f. = 15, p < 0.001, tau 2 = 0.065, I 2 = 98.1%). The meta-regression found that the publication year, sample size, and study quality were not significant moderators for the observed heterogeneity in prevalence. A subgroup analysis according to depression assessment methods showed that the prevalence of depressive disorders was 24.2% (95% CI 16.8–31.6%), and the prevalence of depressive symptoms was 45.1% (95% CI 31.2–59.0%). A subgroup analysis by geographic regions showed that patients in Asia had the highest prevalence of depression at 48.5% (95% CI 26.0–71.0%), compared to other regions. A subgroup analysis by study design showed that the prevalence of depression in case–control studies was almost identical to cross-sectional studies. In the case of OR, the pooled OR of depression between patients with melasma and health controls was 1.677 (95% CI 1.163–2.420, p = 0.606, I 2 = 0.0%).

Conclusion

The prevalence of depression was relatively high in patients with melasma, and there was a correlation between melasma and depression, encouraging clinicians to screen for depression in their patients and providing a combination of physical and psychosocial support. If necessary, they should be referred to formal mental health services to seek professional psychological intervention. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/ , CRD42022381378.

Schlagwörter

Stichwörter der Autor:innen

depressionmelasmameta-analysisprevalencesystematic review

Autor:innen und Institutionen

  • First Clinical Medical College of Beijing University of Chinese Medicine, Beijing, China.
  • Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.

Zitieren

APA

Chen, W., Wan, Y., Sun, Y., Gao, C., & Li, J. (2024). Prevalence of depression in melasma: a systematic review and meta-analysis. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1276906

Vancouver

Chen W, Wan Y, Sun Y, Gao C, Li J. Prevalence of depression in melasma: a systematic review and meta-analysis. Frontiers in Psychiatry. 2024;14. doi:10.3389/fpsyt.2023.1276906

BibTeX
@article{Chen2024,
  author = {Chen, Wenjing and Wan, Yue and Sun, Yuan and Gao, Changyong and Li, Jianhong},
  title = {Prevalence of depression in melasma: a systematic review and meta-analysis},
  journal = {Frontiers in Psychiatry},
  year = {2024},
  volume = {14},
  doi = {10.3389/fpsyt.2023.1276906}
}
Kostenlos starten →